Market Overview and Growth Outlook

The Single-Use Systems Market size was US$ 6.0 billion in 2024 and is likely to reach US$ 15.8 billion in 2031. The industry outlook remains strong, with a projected CAGR of 15.1% over the long run, reflecting growing use of disposable systems in biopharmaceutical manufacturing and processing.

“The Single-Use Systems Market is expected to grow at a CAGR of 15.1% during 2025-2031.” Demand is rising because single-use systems support flexible and scalable manufacturing processes. Biopharmaceutical companies can adjust production capabilities based on demand without extensive facility modifications, improving operational agility across clinical and commercial environments.

Request a free sample report:
https://www.stratviewresearch.com/Request-Sample/single-use-systems-market#form

The market forecast is shaped by increasing demand for biologics, including monoclonal antibodies, cell and gene therapies, and vaccines. For executives assessing Single-Use Systems Market size, the core signal is the transition toward disposable bioprocessing platforms that reduce cross-contamination risk and support faster deployment.

Market Segmentation Analysis

Single-Use Systems Market is segmented by Product Type (Media Bags and Containers, Bioreactors, Tangential-Flow Filtration Devices, Depth Filters, Disposable Fiber Cartridges, Mixing Systems, Tubing Assemblies, Sampling Systems, and Other Products), by Method Type (Filtration, Cell Culture, Purification, Mixing, and Storage), by Application Type (Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, Patient Specific Cell Therapies, and Other Applications), by End-User Type (Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research, and Contract Research Organizations & Manufacturers), and by Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The UK, Spain, Italy, Turkey, and Rest of Europe], China, Rest of Asia-Pacific [Japan, India, Australia, and Others], and Rest of the World [Brazil, Argentina, South Africa, and Others]).

Media bags and containers are likely to be the dominant product category during the forecast period. Their demand is supported by flexibility, scalability, cost-effectiveness, and the elimination of cleaning and validation between batches. Bioreactor is estimated to witness the fastest growth as flexible production requirements expand.

Filtration is anticipated to remain the dominant category of the market during the forecast period. It is a fundamental biopharmaceutical processing step for separating impurities and particulate matter from the desired product. Purification is estimated to witness the fastest growth in the years to come.

Monoclonal antibody production is expected to remain the dominant category of the market in the coming years. Its dominance is linked to high demand, large-scale manufacturing needs, and compatibility with flexible, contamination-free single-use technologies. Patient-specific cell therapies are estimated to be the fastest-growing segment.

Biopharmaceutical manufacturers are expected to remain the biggest demand generator of the market during the forecast period. Their adoption is supported by increased flexibility, scalability, cost-efficiency, and reduced contamination risks. Contract research organizations & manufacturers are likely to witness the fastest growth.

Regional Market Insights

North America is anticipated to be the dominant region in the Single-Use Systems Market during the forecast period. Key factors include an advanced biopharmaceutical industry, strong regulatory support, high R&D expenditures, rapid innovation, and use of new technologies in biopharmaceutical production.

China is likely to witness the fastest growth in the coming years. The source identifies rising healthcare expenditure and the active presence of major companies such as Danaher Corporation, Merck KGaA, Sartorius AG, and Thermo Fischer Scientific, Inc. as growth-supporting factors.

Emerging Trends Shaping the Single-Use Systems Market

The market is evolving as single-use technologies become essential enablers of innovation and agility in biopharmaceutical production. Their value is strongest where scalability, speed, and containment are critical, including early-stage R&D and clinical trials.

The COVID-19 pandemic accelerated adoption as companies sought scalable, flexible, and rapid-deployment manufacturing platforms. This created a stronger operating case for disposable technologies across urgent production environments, especially where fast capacity adjustment was required.

Digitization and automation are improving process control, traceability, and compliance. At the same time, sustainability initiatives are influencing vendors to develop recyclable or lower-waste SUS products, adding another layer to growth trends in the industry.

Key Growth Drivers of the Market

• Rising demand for biologics is increasing the need for manufacturing systems that can support monoclonal antibodies, vaccines, and cell & gene therapies.
• Reduced setup and validation times enable faster time-to-market, helping manufacturers respond more efficiently to production requirements.
• Lower capital and operational expenses improve cost-effectiveness, making disposable technologies attractive for scalable bioprocessing environments.
• Reduced cross-contamination risk strengthens adoption in applications where containment and product integrity are critical operating requirements.
• Expanding regulatory support for single-use technologies supports wider adoption across clinical, commercial, and outsourced biopharmaceutical manufacturing models.

Competitive Landscape

Top Companies in the Market

Sartorius AG
Danaher Corporation
Thermo Fisher Scientific Inc.
Merck KGaA

Conclusion and Strategic Outlook

The Single-Use Systems Market is expected to advance from US$ 6.0 billion in 2024 to US$ 15.8 billion in 2031, supported by a CAGR of 15.1%. The growth analysis points to strong demand from biologics, vaccines, monoclonal antibodies, and cell and gene therapy manufacturing.

The strategic outlook remains positive as disposable systems help manufacturers improve flexibility, reduce contamination risk, and scale production faster. The competitive landscape is likely to remain focused on service offerings, regional presence, price, and bioprocessing capability.

FAQs – Single-Use Systems Market

What is the Single-Use Systems Market size?

The Single-Use Systems Market size was US$ 6.0 billion in 2024. It is likely to reach US$ 15.8 billion in 2031.

What CAGR is expected for the Single-Use Systems Market?

The Single-Use Systems Market is expected to grow at a CAGR of 15.1% during 2025-2031. This indicates a robust long-term growth trajectory.

Why is demand increasing in the Single-Use Systems Market?

Demand is increasing due to biologics growth, reduced setup and validation time, cost-effectiveness, and lower cross-contamination risk. Adoption by CDMOs and small biotech firms is also supporting market expansion.

Which region dominates the Single-Use Systems Market?

North America is anticipated to remain the dominant region during the forecast period. China is expected to witness the fastest growth.

What is the strategic outlook for the Single-Use Systems Market?

The Single-Use Systems Market outlook remains strong because the forecast indicates US$ 15.8 billion by 2031. The source page does not explicitly state risks or challenges.